Healthcare & Biotechnology stocks

2 out of 2 — this analysis has once again been a major success. We are now officially deactivating our second

This was a clear success — we are now officially deactivating our defined Fibonacci buying zone. The chart shown at the

This worked out perfectly. In our previous analysis, Canopy Growth reached and activated our defined Fibonacci retracement zone, which we

Hims & Hers has activated our Fibonacci buying zone In our previous analysis update, we defined a Fibonacci retracement zone

Tilray has now entered and activated our Fibonacci buying zone. In our previous analysis from March 5th, 2026, we outlined

We have defined a new Fibonacci retracement zone for potential new acquisitions. Hims & Hers has successfully completed its long-term